Abstract
Methicillin-resistant Staphylococcus aureus (MRSA) has been recognized as an in-hospital acquired pathogen responsible for an increasing number of cases of hospital and ventilator associated pneumonia. However, this previously considered a purely nosocomial pathogen has been diagnosed with increasing frequency at hospital admission and new infections and outbreaks have been reported in individuals from the community with absence of risk factors. This new strain of MRSA is currently recognized in the literature as community-associated MRSA (CA-MRSA). The spectrum of infections due to CA-MRSA can range from simple cutaneous abscesses and soft tissue infections to septic shock and severe necrotizing pneumonia. CA-MRSA pneumonia usually presents in a previously healthy individual with the presence of a previous influenza like illness followed by shortness of breath, bilateral pulmonary infiltrates, sepsis and prompt clinical detriment and death if no proper treatment is established soon. The objective of this review is to familiarize the clinician with CA-MRSA as cause of community acquired pneumonia, review the epidemiological, clinical, microbiological characteristics, in order to minimize delays in the administration of the adequate antimicrobial treatment to improve patients outcomes of this deadly condition.
Keywords: Pneumonia, MRSA, microbiology, diagnosis, antimicrobials
Current Respiratory Medicine Reviews
Title: Community-Associated Methicillin Resistant Staphylococcus aureus Pneumonia (CA-MRSA)
Volume: 6 Issue: 3
Author(s): Marcela Mazo, John E. Stupka, Eric M. Mortensen, Antonio Anzueto and Marcos I. Restrepo
Affiliation:
Keywords: Pneumonia, MRSA, microbiology, diagnosis, antimicrobials
Abstract: Methicillin-resistant Staphylococcus aureus (MRSA) has been recognized as an in-hospital acquired pathogen responsible for an increasing number of cases of hospital and ventilator associated pneumonia. However, this previously considered a purely nosocomial pathogen has been diagnosed with increasing frequency at hospital admission and new infections and outbreaks have been reported in individuals from the community with absence of risk factors. This new strain of MRSA is currently recognized in the literature as community-associated MRSA (CA-MRSA). The spectrum of infections due to CA-MRSA can range from simple cutaneous abscesses and soft tissue infections to septic shock and severe necrotizing pneumonia. CA-MRSA pneumonia usually presents in a previously healthy individual with the presence of a previous influenza like illness followed by shortness of breath, bilateral pulmonary infiltrates, sepsis and prompt clinical detriment and death if no proper treatment is established soon. The objective of this review is to familiarize the clinician with CA-MRSA as cause of community acquired pneumonia, review the epidemiological, clinical, microbiological characteristics, in order to minimize delays in the administration of the adequate antimicrobial treatment to improve patients outcomes of this deadly condition.
Export Options
About this article
Cite this article as:
Mazo Marcela, E. Stupka John, M. Mortensen Eric, Anzueto Antonio and I. Restrepo Marcos, Community-Associated Methicillin Resistant Staphylococcus aureus Pneumonia (CA-MRSA), Current Respiratory Medicine Reviews 2010; 6 (3) . https://dx.doi.org/10.2174/157339810791526201
DOI https://dx.doi.org/10.2174/157339810791526201 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Peptide Self-Assembly for Therapeutic Applications
Current Organic Chemistry Hitting the Golden TORget: Curcumin’s Effects on mTOR Signaling
Anti-Cancer Agents in Medicinal Chemistry The Use of Methylphenidate for Physical and Psychological Symptoms in Cancer Patients: A Review
Current Drug Targets Systemic Lupus Erythematosus: Old and New Susceptibility Genes versus Clinical Manifestations
Current Genomics Patented Biomarker Panels in Early Detection of Cancer
Recent Patents on Biomarkers Control of Neuropathic Pain by Immune Cells and Opioids
CNS & Neurological Disorders - Drug Targets Medical Therapy and Mucosal Healing
Current Drug Targets Boronic Acid Based Inhibitors of Autotaxin: Understanding their Biological Role in Terms of Quantitative Structure Activity Relationships (QSAR)
Letters in Drug Design & Discovery Functional Relevance of Biased Signaling at the Angiotensin II Type 1 Receptor
Endocrine, Metabolic & Immune Disorders - Drug Targets Statistical Analysis, Optimization, and Prioritization of Virtual Screening Parameters for Zinc Enzymes Including the Anthrax Toxin Lethal Factor
Current Topics in Medicinal Chemistry Dasatinib in the Treatment of Chronic Myeloid Leukemia
Current Signal Transduction Therapy Chinese Medicine in Inhalation Therapy: A Review of Clinical Application and Formulation Development
Current Pharmaceutical Design Innovative formulations for controlled drug delivery to the lungs and the technical and toxicological challenges to overcome<sup>#</sup>
Current Pharmaceutical Design Biomolecular Pathogenesis of Borderline Ovarian Tumors: Focusing Target Discovery Through Proteogenomics
Current Cancer Drug Targets Adenosine in the Central Nervous System: Effects on Neurotransmission and Neuroprotection
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Intraperitoneal Drug Therapy: An Advantage
Current Clinical Pharmacology Mutational Testing in Gastrointestinal Stromal Tumor
Current Cancer Drug Targets <i>Propionibacterium acnes</i> in the Pathogenesis and Immunotherapy of Acne Vulgaris
Current Drug Metabolism The Coordinated Role of CYP450 Enzymes and P-gp in Determining Cancer Resistance to Chemotherapy
Current Drug Metabolism PEO-PPO Block Copolymers for Passive Micellar Targeting and Overcoming Multidrug Resistance in Cancer Therapy
Current Drug Targets